Fig. 5From: HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patientsDiagnostic performance of CA125, HE4 and ROMA for the differential diagnosis of early stage ovarian cancer and endometriosisBack to article page